In Vivo Dissolution: Predominant Factor Affecting the Bioavailability of Rifampicin in its Solid Oral Dosage Forms.

Autor: Ashokraj, Yasvanth1 (AUTHOR), Kaur, Kanwal Jit1 (AUTHOR), Singh, Inderjit1 (AUTHOR), Kohli, Gunjan1 (AUTHOR), Bhade, Shantaram Ramdoss1 (AUTHOR), Varma, Manthena1 (AUTHOR), Agrawal, Shrutidevi1 (AUTHOR), Panchagnula, Ramesh1 (AUTHOR) Ramesh.panchagnula@pfizer.com
Zdroj: Clinical Research & Regulatory Affairs. Mar2008, Vol. 25 Issue 1, p1-12. 12p. 1 Chart, 2 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje